Abstract
Various clinical and laboratory observations suggest that the leukaemia cells in chronic myeloid leukaemia (CML) are potentially immunogenic. Whilst the ability of the leukaemia cells to elicit an anti-leukaemic immune response in the allogeneic setting is established, it remains unclear why such anti-leukaemic response does not occur in vivo in the autologous setting. We previously demonstrated the presence of leukaemia-reactive T cells in a patient with CML. However, we found that the T cells were normally anergic unless pre-incubated in vitro in high-dose recombinant interleukin-2. We speculated that the T cell anergy was the result of a lack of the appropriate immune costimulatory molecules on the leukaemia cell surface. In this study, we confirm the absence of immune costimulatory molecules, CD80 (B7-1) and CD86 (B7-2), on leukaemia cells and demonstrated that these costimulatory molecules on the leukaemia cells can be upregulated by a combination of GM-CSF and IL-4. There was an associated restoration of leukaemia cell immunogenicity to autologous T cells in mixed lymphocyte leukaemia reactions, suggesting a possible enhancement of anti-leukaemic reaction. More importantly, T cells primed with ‘activated’ leukaemia cells were able to recognise fresh cytokine-naive leukaemia cells. Furthermore, leukaemia cells expressing the dendritic cell marker, CD1a, were also generated. Our findings therefore suggest the opportunity in future to use these combination cytokines in vivo or these leukaemia cells which have been activated in vitro for leukaemia immunotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coleman, S., Throp, D., Fisher, J. et al. Cytokine enhancement of immunogenicity in chronic myeloid leukaemia. Leukemia 11, 2055–2059 (1997). https://doi.org/10.1038/sj.leu.2400858
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400858
Keywords
This article is cited by
-
Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells
Bone Marrow Transplantation (2004)
-
Interferon-α modulates the immune response enhancing B7-1 and B7-2 costimulatory molecules and T8 lymphocytes in chronic myeloid leukemia
Leukemia (2003)
-
Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells
Leukemia (2003)
-
Identification of precursors of leukemic dendritic cells differentiated from patients with acute myeloid leukemia
Leukemia (2002)
-
Interferon-α induces dendritic cell differentiation of CML mononuclear cells in vitro and in vivo
Leukemia (2002)